The diagnostics business unit formerly known as Bristol-Myers Squibb Medical Imaging is now an independent firm called Lantheus Medical Imaging, the N. Billerica, MA–based company announced today. The news follows the sale of the unit to private equity firm Avista Capital Partners, which was announced in December. Lantheus makes a suite of diagnostic products including the heart imaging agent Cardiolite, one of the top royalty earners in MIT’s patent portfolio.
Author: Rebecca Zacks
Rebecca is Xconomy's co-founder. She was previously the managing editor of Physician's First Watch, a daily e-newsletter from the publishers of New England Journal of Medicine. Before helping launch First Watch, she spent a decade covering innovation for Technology Review, Scientific American, and Discover Magazine's TV show. In 2005-2006 she was a Knight Science Journalism Fellow at MIT. Rebecca holds a bachelor's degree in biology from Brown University and a master's in science journalism from Boston University.
View all posts by Rebecca Zacks
